Patents by Inventor William Harnett

William Harnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunomodulatory compounds
    Patent number: 9598386
    Abstract: This invention relates to compounds and uses thereof in the treatment or prophylaxis of diseases associated with inflammation.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: March 21, 2017
    Assignees: University of Strathclyde, University of Glasgow
    Inventors: Margaret Harnett, William Harnett, Colin J. Suckling, Fraser Scott, Judith K. Huggan, Abedawn I. Khalaf
  • Immunomodulatory Compounds
    Publication number: 20150218116
    Abstract: This invention relates to compounds and uses thereof in the treatment or prophylaxis of diseases associated with inflammation.
    Type: Application
    Filed: July 25, 2013
    Publication date: August 6, 2015
    Inventors: Margaret Harnett, William Harnett, Colin J. Suckling, Fraser Scott, Judith K. Huggan, Abedawn I. Khalaf
  • Compositions and methods of use for anti-inflammatory agents
    Patent number: 7067480
    Abstract: This invention relates to the use of a phosphorylcholine-containing glycoprotein in the treatment or prophylaxis of diseases associated with inflammation. In particular, the present invention relates to the use of ES-62 for the treatment or prophylaxis of autoimmune diseases associated with abnormal inflammation, such as rheumatoid arthritis.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: June 27, 2006
    Assignees: University of Strathclyde, The University Court of the University of Glasgow
    Inventors: William Harnett, Margaret M. Harnett, Iain B. McInnes
  • Anti-inflammatory agent
    Publication number: 20050032686
    Abstract: This invention relates to the use of a phosphorylcholine-containing glycoprotein in the treatment or prophylaxis of diseases associated with inflammation. In particular, the present invention relates to the use of ES-62 for the treatment or prophylaxis of autoimmune diseases associated with abnormal inflammation, such as rheumatoid arthritis.
    Type: Application
    Filed: September 20, 2002
    Publication date: February 10, 2005
    Inventors: William Harnett, Margaret Harnett, Iain McInnes